Canopy Growth (CGC) Income from Continuing Operations (2019 - 2025)

Canopy Growth's (CGC) quarterly Income from Continuing Operations came in at 44908962.65 in Q4 2025, up 48.53% year-on-year from 30234842.93 in Q4 2024, and down 3670.84% quarter-over-quarter from 1190954.77 in Q3 2025.

Canopy Growth (CGC) Income from Continuing Operations (2019 - 2025) Analysis & Trends

Canopy Growth has disclosed Income from Continuing Operations across 7 years of filings, most recently posting 44908962.65 for Q4 2025.

  • Income from Continuing Operations for Q4 2025 came in at 44908962.65, up 48.53% year-over-year; the trailing twelve-month figure through Dec 2025 was 456064284.46 (up 330.29% YoY), and the FY2025 annual result was 265468727.16, up 227.28% from the prior year.
  • Income from Continuing Operations came in at 44908962.65 for Q4 2025 at Canopy Growth, down from 1190954.77 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 532134756.83 in Q1 2025 to a low of 1640644562.36 in Q2 2022.
  • The 5-year median for Income from Continuing Operations is 93041961.25 (2024), against an average of 146192651.12.
  • Across the five-year window, Income from Continuing Operations sank 1100.5% in 2024 and jumped 564.23% in 2025, its largest moves.
  • Canopy Growth's Income from Continuing Operations stood at 91627144.08 in 2021, then slumped by 82.39% to 167116641.72 in 2022, then declined by 1.21% to 169145903.03 in 2023, then soared by 48.41% to 87259146.83 in 2024, then surged by 48.53% to 44908962.65 in 2025.
  • The last three Income from Continuing Operations figures came in at 44908962.65 (Q4 2025), 1190954.77 (Q3 2025), and 29970554.96 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 370.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 21.05 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -66.53 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 118.42 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -92.12 Mn
10 Canopy Growth 11.38 Mn -137.31 Mn 15.39 Mn -44.91 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -44.91 Mn
Sep 30, 2025 -1.19 Mn
Jun 30, 2025 -29.97 Mn
Mar 31, 2025 532.13 Mn
Dec 31, 2024 -87.26 Mn
Sep 30, 2024 -96.43 Mn
Jun 30, 2024 -94.46 Mn
Mar 31, 2024 80.11 Mn
Dec 31, 2023 -169.15 Mn
Sep 30, 2023 -110.52 Mn
Jun 30, 2023 -7.87 Mn
Mar 31, 2023 -436.13 Mn
Dec 31, 2022 -167.12 Mn
Sep 30, 2022 -150.64 Mn
Jun 30, 2022 -1.64 Bn
Mar 31, 2022 -282.69 Mn
Dec 31, 2021 -91.63 Mn
Sep 30, 2021 -12.97 Mn
Jun 30, 2021 317.24 Mn
Mar 31, 2021 -429.77 Mn